Summary
This study by K. Gransbury, G. et al was published in 2016. It utilized Microtissues 3D Petri Dish® micro-molds for 3D cell culture, contributing to advances in other research.
Comparison of KP1019 and NAMI-A in tumour-mimetic environments
Research Overview
The ruthenium(III) anticancer agents NAMI-A and KP1019 are thought to activate by reduction to Ru(II) — a reaction favored in the hypoxic core of tumors. To test this in a tissue-like setting, the study modeled normoxic, hypoxic, and necrotic tumor regions using multicellular SH-SY5Y neuroblastoma spheroids spanning 50–800 µm, confirming the internal oxygen gradient by pimonidazole staining.
Laser-ablation ICP-MS showed both drugs penetrating into the hypoxic region. XANES spectroscopy found NAMI-A biotransformation products unchanged as hypoxia increased, while KP1019 metabolites showed a Ru K-edge shift correlating with spheroid hypoxia — consistent with partial Ru(III)-to-Ru(II) reduction inside the tissue.
Key Discoveries
- Utilized Microtissues 3D Petri Dish® micro-molds for reproducible 3D spheroid formation
- Enabled physiologically relevant cell-cell interactions in a controlled 3D environment
- Supported the study of complex biological processes that cannot be replicated in traditional 2D culture
3D Petri Dish® Application
3D Petri Dish® Application
- Non-adhesive hydrogel micro-molds promoted self-assembly of cells into 3D spheroids:
- Uniform microtissue size ensured experimental reproducibility:
- Compatible with standard cell culture workflows and imaging techniques:
